| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 03/19/2008 | EP1149091B1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 03/19/2008 | CN101146536A Drug delivery systems for treatment of diseases or conditions |
| 03/19/2008 | CN101146516A Treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells |
| 03/19/2008 | CN101143207A Application of natural type, breaking type or No. 5 domain delation variant type beta 2 glycoprotein I in preparing medicine for inhibiting blood vessel newborn |
| 03/19/2008 | CN100375746C Process for preparing decumbent corydalis tuber total alkaloid and its preparation and quality detecting method |
| 03/18/2008 | US7345151 Antagonists specific for denatured collagen and methods of using same |
| 03/18/2008 | US7345077 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4- (substituted cycloalkylmethyl) imidazol-2-ones and 4- (substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
| 03/18/2008 | US7345066 Use of thiazole derivatives for preparing a medicine for protecting mitochondria |
| 03/18/2008 | US7345023 Treatment of hyperproliferative conditions of body surfaces |
| 03/18/2008 | CA2380326C Novel 2-decarboxy-2-phosphinico prostaglandin f analogs |
| 03/18/2008 | CA2089735C Ryegrass pollen allergen |
| 03/18/2008 | CA2015060C Novel antibody delivery system for biological response modifiers |
| 03/13/2008 | WO2008031048A2 Enhanced mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes |
| 03/13/2008 | WO2008031028A2 Methods of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes |
| 03/13/2008 | WO2008029924A1 Cyclic aminoalkylcarboxamide derivative |
| 03/13/2008 | WO2008029868A1 Ocular fibrous neovascularization inhibitor |
| 03/13/2008 | WO2008029825A1 Imidazole derivative |
| 03/13/2008 | WO2008008718A3 Cyclopentane derivatives as antiglaucoma agents |
| 03/13/2008 | WO2008007149A3 New medical use of triazine derivatives |
| 03/13/2008 | WO2007130890A3 Cyclopentane-derivatives and their use as ocular hypotensive agents |
| 03/13/2008 | WO2007125566A3 Use of probiotics in the prevention and treatment of allergic conjunctivitis |
| 03/13/2008 | WO2006078731A3 Amorphous and crystalline forms of dorzolamide hydrochloride and processes of making same |
| 03/13/2008 | US20080064753 Interleukin-1 and tumor necrosis factor-alpha modulators; syntheses of such modulators and methods of using such modulators |
| 03/13/2008 | US20080064720 Very Late Antigen-4 dependent inflammatory disease; asthma, allergic rhinitis, sinusitis, conjunctivitis, food allergy, inflammatory skin disorders, autoimmune disorders, or atherosclerosis, inflammatory skin disorder; methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-hydroxy-2-propenoate |
| 03/13/2008 | US20080064687 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea |
| 03/13/2008 | US20080064650 Therapeutic uses of inhibitors of RTP801L |
| 03/13/2008 | US20080064633 Preventing fibronectin deposition and fibrosis; phospholipase A2 inhibition; cystic fibrosis |
| 03/13/2008 | US20080063688 Biomedical devices with antimicrobial coatings |
| 03/13/2008 | CA2662112A1 Imidazole derivatives and their use as cannabinoid type 2 (cb2) receptor modulators |
| 03/12/2008 | EP1897546A1 Combined compositions comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid |
| 03/12/2008 | EP1897441A1 TGF-alpha polypeptides, functional fragments and methods of use therefor |
| 03/12/2008 | EP1896084A2 Rnai modulation of hif-1 and theraputic uses thereof |
| 03/12/2008 | EP1758567A4 Partially-fluorinated ethers, compositions and uses thereof, for long-term tamponade in the eye |
| 03/12/2008 | EP1539693B1 Cannabinoid receptor agonists |
| 03/12/2008 | EP1534275B1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 03/12/2008 | EP1128830B1 Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts |
| 03/12/2008 | CN101139393A KDR peptides and vaccines containing the same |
| 03/12/2008 | CN101139392A KDR peptides and vaccines containing the same |
| 03/12/2008 | CN101138582A Use of compound red sage root tablet for producing medicine for preventing and treating diabetes chronic complication |
| 03/12/2008 | CN101138575A Prescription of chrysanthemum lozenge having functions os getting rid of the hot temper and beneficial to one's eyes |
| 03/12/2008 | CN101138566A Prevention and treatment process for infectious diseases and other diseases by using immunity effect compounds |
| 03/12/2008 | CN100374161C Triacetin as a transdermal penetration enhancer |
| 03/12/2008 | CN100374142C Natural herbal eye-care cream |
| 03/12/2008 | CN100374114C Antibiotic compositions for treatment of the eye, ear and nose |
| 03/11/2008 | US7342125 Administering derivatives of Kauranoic acid; cachexia, analgesics, in treating immune disorders, as anti-cancer and anti-tumor agents, otitis media, sinusitis, antidiabetic agent |
| 03/11/2008 | US7342032 Psychiatric and neurological disorders; cannabinoid (cb1) receptor; such as 4-(4-Chlorophenyl)-5-(2,4-dichlorophenyl)-N-(1-piperidinyl)thiazole-2-carboxamide |
| 03/11/2008 | US7342017 Vanilloid Receptor 1 and metabotropic glutamate receptor 1 inhibitors; inhibition of capsaicin-induced or PH-induced activation of vanilloid receptors; antidepressant; anxiolytic agent; analgesics; addictive disorders; antiemetic agent |
| 03/11/2008 | CA2396130C Preparation of irrigating solution for ocular surgery |
| 03/06/2008 | WO2008027880A2 Strontium-based treatment of otosclerosis |
| 03/06/2008 | WO2008026962A1 Agent for treating eye diseases |
| 03/06/2008 | WO2008026756A1 Ophthalmic percutaneous absorption type preparation |
| 03/06/2008 | WO2008026704A1 Isoquinoline derivative |
| 03/06/2008 | WO2008026687A1 Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor comprising the derivative |
| 03/06/2008 | WO2008026320A1 ANTI-ANGIOGENIC AGENT, DNA SYNTHESIS INHIBITOR, p44/p42 MAPK PHOSPHORYLATION ACTIVITY INHIBITOR, AND MEDICAL KIT |
| 03/06/2008 | WO2007149829A3 Therapeutic compounds |
| 03/06/2008 | WO2007140136A3 Therapeutic cyclopentane derivatives |
| 03/06/2008 | WO2007126364A3 Use of antisecretory factors for treating intraocular hypertension |
| 03/06/2008 | WO2007100664A3 Modulators of muscarinic receptors |
| 03/06/2008 | WO2007000641A8 Prostaglandin derivatives |
| 03/06/2008 | US20080058514 ceramide-like inhibitors; novel intermediates formed during the synthesis; Glycosphingolipids |
| 03/06/2008 | US20080058414 Substituted Cyclopentanes Or Cyclopentanones As Therapeutic Agents |
| 03/06/2008 | US20080058403 Administering photoactive porphyrin, and awaiting localization in ocular tissue; radiating with laser light; macular degeneration; neovascularization |
| 03/06/2008 | US20080058397 Therapeutic substituted hydantoins and related compounds |
| 03/06/2008 | US20080058392 Prostaglandin derivatives |
| 03/06/2008 | US20080058387 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds |
| 03/06/2008 | US20080058373 Compositions and Methods for Treating or Preventing Glaucoma or Progression Thereof |
| 03/06/2008 | US20080058359 1-[[3-[(1,4,5,6-Tetrahydro-2-pyrimidinyl)amino]phenyl]acetyl]-4-piperidinepropanoic acid; new class of selective modulator of beta 3, beta 5 or dual integrin receptors; anticarcinogenic, antiinflammatory, antidiabetic agent |
| 03/06/2008 | US20080058354 Treating erectile dysfunction and female sexual dysfunction; side effect reduction; 1-ethyl-3-(2-hydroxyethyl)-7-(3-bromo-4-methoxyphenyl)-8-(2-hydroxycyclopenylamino)-1,2,3,6-tetrahydro-7H-purine-2,6-dione for example |
| 03/06/2008 | US20080057072 Antagonists of ci-m6p/igf2r for prevention and treatment of ctgf-mediated ocular disorders |
| 03/06/2008 | US20080057023 comprising a solution of an aqueous ophthalmic agent such as artificial tears and oxygen |
| 03/06/2008 | US20080057022 sustained release mixture of polymers, drugs such as antiallergens, antiinflammatory agents or antiseptics, flow control agents and carriers, used for providing relief to discomfort of eyes |
| 03/06/2008 | CA2662114A1 Agent for treating eye diseases |
| 03/06/2008 | CA2661850A1 Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor containing the same |
| 03/05/2008 | EP1893292A2 Method to treat and prevent posterior capsule opacification |
| 03/05/2008 | EP1893231A2 Use of plasmin for preventing of reducing the rate of the progression of non-proliferative diabetic retinopathy and the treatment of other ocular conditions |
| 03/05/2008 | EP1893219A2 Use of spirostenols to treat mitochondrial disorders |
| 03/05/2008 | EP1368020B1 Method for identifying maxi-k channel blockers |
| 03/05/2008 | CN101137754A Rnai-mediated inhibition of frizzled related protein-1 for treatment of glaucoma |
| 03/05/2008 | CN101137622A Substituted gamma lactams as therapeutic agents |
| 03/05/2008 | CN101137383A 增强型比马前列素眼用溶液 Enhanced bimatoprost ophthalmic solution |
| 03/05/2008 | CN101137359A Methods of treating ear infections |
| 03/05/2008 | CN101137347A Active substance delivery system comprising a hydrogel atrix and microcarriers |
| 03/05/2008 | CN101134775A Novel streptococcus antigens |
| 03/05/2008 | CN101134064A Traditional Chinese medicine ophthalmology department antisenescence recovering paste, liquid and pellets |
| 03/05/2008 | CN100372846C Sulfonamido substituted imidazopyridines |
| 03/05/2008 | CN100372560C Medicine for treating congenital deafmutism |
| 03/04/2008 | US7339047 Comprises nucleotide sequences coding interleukin-1b converting enzyme ligand for use in diagnosis, prevention and treatment of autoimmune, connective tissue and crohn's diseases |
| 03/04/2008 | US7339023 Angiogenesis inhibitors, antitumor agents |
| 03/04/2008 | US7338976 Administering heterocyclic esters and amides: 3-phenyl-1-propyl(2S)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-(4-thiazolidine)carboxylate; 3-phenyl-1-propyl (2S)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-pyrrolidinecarboxylate; immunosuppressants; affinity for an FK binding protein-type immunophilin |
| 02/28/2008 | WO2008024734A2 Use of pkc inhibitors in particular indolylmaleimide derivatives in ocular diseases |
| 02/28/2008 | WO2008023784A1 Agent for amelioration of ophthalmic circulatory disorder |
| 02/28/2008 | WO2008023717A1 Ophthalmic agent comprising pacap peptide |
| 02/28/2008 | WO2008008701A3 Substituted cyclopentane derivatives as therapeutic agents |
| 02/28/2008 | WO2008008700A3 Substituted cyclopentane derivatives as therapeutic agents |
| 02/28/2008 | WO2008006235A3 Scfv antibodies which pass epithelial and/or endothelial layers |
| 02/28/2008 | WO2007128526A3 Combination comprising a vegf inhibitor and a serine protease for treating neovascular diseases |
| 02/28/2008 | US20080051423 Nitrogen heterocycle biaryls for osteoporosis and other diseases |
| 02/28/2008 | US20080051406 Brimonidine and timolol compositions |
| 02/28/2008 | US20080051385 Ocular allergy treatments |
| 02/28/2008 | US20080051374 ophthalmically acceptable for reducing intraocular pressure |